Eli Lilly And Co (LLY) Stock Price Today
Aura AI Summary
Key Stats
- $1.03TMarket Cap
- 1,879,873Volume
- HealthSector
- $1.28K52W High
- $714.5952W Low
- 92 DaysTypical Hold Time
- $1.07TEnterprise Value
- 0.6%Div Yield
- 63% Sell | 37% BuyTrading Activity
Track Eli Lilly And Co (LLY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Eli Lilly And Co has traded between a low of $714.59 and a high of $1,280.74, highlighting its annual price range. Buy and sell Eli Lilly And Co shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Most Recent News
On Holding enters football market with Kylian Mbappé partnership, shares volatile despite 'Underperform' rating.
On Holding, a Swiss athletic shoe company, is expanding into the global football market by partnering with soccer star Kylian Mbappé, who leaves Nike after nearly 20 years. This marks On Holding's first venture into football cleats and apparel, lever...

Peter Thiel's fund re-enters market with $419M, heavily investing 72% in energy and power sectors.
Peter Thiel's investment fund, which held no stocks for two consecutive quarters, has made a significant comeback with $419 million in new investments. Notably, 72% of this capital has been allocated to the energy and power sectors, signaling a strat...

Vanguard FTSE All-World ex-US ETF offers strong value with 12.5x P/E and 8% earnings yield, supported by AI-driven growth in Asia.
The Vanguard FTSE All-World ex-US ETF (VEU) currently trades at a compelling valuation of about 12.5 times price-to-earnings with an 8% earnings yield, outperforming the SPY year-to-date despite a stronger dollar. Its broad diversification, solid mom...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.